Form 4: Bausch Health Director Brett Icahn Acquires Shares Through Restricted Stock Units

Brett Icahn, a director at Bausch Health Companies Inc., acquired 4,109 common shares through restricted stock units as part of his board compensation.

Summary

• Brett Icahn, a director of Bausch Health Companies Inc., acquired 4,109 common shares on December 31, 2024.
• These shares were obtained through restricted stock units (RSUs) granted in lieu of cash compensation for his service on the board.
• The RSUs represent a contingent right to receive one common share each.
• The transaction price was $8.06 per share.
• Following this transaction, Mr. Icahn's total holdings increased to 156,780 shares.

Sentiment

Score: 6

Explanation: The document reflects a routine transaction related to director compensation. It is neither particularly positive nor negative, but indicates alignment of interests.

Positives

• The acquisition of shares by a director can be seen as a positive sign of confidence in the company's future.

Industry Context

This is a routine filing related to director compensation and is not indicative of any broader industry trends.

Comparison to Industry Standards

• Director compensation through stock grants is a common practice across publicly traded companies.
• The use of restricted stock units (RSUs) is a standard method for aligning director interests with shareholder value.
• The specific number of shares and value will vary based on the company's size, performance, and compensation policies.

Stakeholder Impact

• The share acquisition by a director may be viewed positively by shareholders as it aligns the director's interests with the company's performance.

Key Dates

Keywords

Bausch Health, Brett Icahn, Director, Share Acquisition, Restricted Stock Units, Board Compensation, SEC Form 4